Key Updates in Fundamentals of the Use of Opioids for Pain Management and Prevention, Identification, and Mitigation of Non-medical Use of Prescription Opioids: A REMS-Compliant Continuing Education Program
FACULTY
Geoffrey C. Wall, Pharm.D., FCCP, BCPS
John R. Ellis Distinguished Chair of Pharmacy Practice
Professor of Clinical Sciences
Director, Drake Drug Information Center
Drake University College of Pharmacy and Health Sciences
Internal Medicine Clinical Pharmacist
Iowa Methodist Medical Center
Des Moines, IA
PROGRAM DESCRIPTION
This video docuseries offers personal perspectives from clinicians and patients on the management of chronic pain and addiction. Participants will explore the fundamentals of addiction medicine, including strategies to identify patients at risk for opioid misuse, approaches to managing chronic pain in individuals with opioid use disorder, and best practices for counseling and referring at-risk patients. The series also addresses the impact of stigmatizing language on patient outcomes, emphasizing the importance of compassionate communication.
REMS-COMPLIANT PROGRAM COMPLETION
In order to be considered a completer of this REMS-compliant education, learners must complete three of the following activities in this series: one track of this Sim Center activity, the Holovision activity and one chapter of the Day in the Life docuseries. Each activity can be found on the RESTORE website when they are made available: https://restore-painrelief.com/cme-bridge/?portal=clinician.
TARGET AUDIENCE
Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of health care professionals, including physicians, advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.
LEARNING OBJECTIVES
- Appraise best practices in patient and caregiver counseling regarding the safe use of naloxone for opioid overdose including proper and safe storage
- Describe the fundamental elements of addiction medicine and best practices for the identification and management of patients with opioid use disorder, including the discussion of the removal of stigmatizing language
JOINT ACCREDIDATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 0.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 0.5 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designed for 0.5 AAPA Category 1 CME credit. Approval is valid until 1/1/26. PAs should only claim credit commensurate with the extent of their participation.
ADA CREDIT DESIGNATION STATEMENT
Med Learning Group is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
Med Learning Group designates this activity for 0.5 continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
COPE CREDIT DESIGNATION STATEMENT
Med Learning Group designates this asynchronous activity for 0.5 COPE hours. Activity number 129875. Course number 95619-PH.
MATE ACT Designation Statement
This activity meets the MATE requirements set by the DEA and SAMHSA by covering prevention, recognition, and care of people with substance use disorders including those with concurrent pain and/or psychiatric and medical co-morbidities. This activity covers categories of substance use disorders, effective treatment planning, pain management and substance misuse. Completion of this activity will contribute to the 8 hour requirement set in the MATE ACT.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Geoffrey C. Wall, Pharm.D., FCCP, BCPS | Has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Nicole Longo, DO, FACOI, VP Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
- Lauren Scott, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Program Director for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.  In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at info@medlearninggroup.com
RELEASED DATE: January 01, 2025
EXPIRATION DATE: January 01, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
James Q. Zhou, MD
Attending Physician, Addiction Consult Team
Department of Medicine
Massachusetts General Hospital
Instructor, Harvard Medical School
Boston, MA
Featuring
Sherry Overka
Boston, MA
PROGRAM DESCRIPTION
This video docuseries offers personal perspectives from clinicians and patients on the management of chronic pain and addiction. Participants will explore the fundamentals of addiction medicine, including strategies to identify patients at risk for opioid misuse, approaches to managing chronic pain in individuals with opioid use disorder, and best practices for counseling and referring at-risk patients. The series also addresses the impact of stigmatizing language on patient outcomes, emphasizing the importance of compassionate communication.
REMS-COMPLIANT PROGRAM COMPLETION
In order to be considered a completer of this REMS-compliant education, learners must complete three of the following activities in this series: one track of this Sim Center activity, the Holovision activity and one chapter of the Day in the Life docuseries. Each activity can be found on the RESTORE website when they are made available: https://restore-painrelief.com/cme-bridge/?portal=clinician.
TARGET AUDIENCE
Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of health care professionals, including physicians, advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.
LEARNING OBJECTIVES
- Appraise best practices in patient and caregiver counseling regarding the safe use of naloxone for opioid overdose including proper and safe storage
- Describe the fundamental elements of addiction medicine and best practices for the identification and management of patients with opioid use disorder, including the discussion of the removal of stigmatizing language
JOINT ACCREDIDATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 0.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designed for 0.5 AAPA Category 1 CME credit. Approval is valid until 01/31/2026. PAs should only claim credit commensurate with the extent of their participation.
ADA CREDIT DESIGNATION STATEMENT
Med Learning Group is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
Med Learning Group designates this activity for 0.5 continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
COPE CREDIT DESIGNATION STATEMENT
Med Learning Group designates this asynchronous activity for 0.5 COPE hours. Activity number 129875. Course number 95619-PH.
MATE ACT Designation Statement
This activity meets the MATE requirements set by the DEA and SAMHSA by covering prevention, recognition, and care of people with substance use disorders including those with concurrent pain and/or psychiatric and medical co-morbidities. This activity covers categories of substance use disorders, effective treatment planning, pain management and substance misuse. Completion of this activity will contribute to the 8 hour requirement set in the MATE ACT.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| James Q. Zhou, MD | Has nothing to disclose. |
| Sherry Overka | Has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Nicole Longo, DO, FACOI, VP Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
- Lauren Scott, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.  In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at info@medlearninggroup.com
RELEASED DATE: January 31, 2025
EXPIRATION DATE: January 31, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
FACULTY
Wei Sum Li, MD
Addiction Medicine and Primary Care Physician
Assistant in Medicine
Massachusetts General Hospital
Department of General Internal Medicine and Program in Substance Use & Addiction Services
James Q. Zhou, MD
Attending Physician, Addiction Consult Team
Department of Medicine
Massachusetts General Hospital
Instructor, Harvard Medical School
Boston, MA
PROGRAM DESCRIPTION
This video docuseries offers personal perspectives from clinicians and patients on the management of chronic pain and addiction. Participants will explore the fundamentals of addiction medicine, including strategies to identify patients at risk for opioid misuse, approaches to managing chronic pain in individuals with opioid use disorder, and best practices for counseling and referring at-risk patients. The series also addresses the impact of stigmatizing language on patient outcomes, emphasizing the importance of compassionate communication.
REMS-COMPLIANT PROGRAM COMPLETION
In order to be considered a completer of this REMS-compliant education, learners must complete three of the following activities in this series: one track of this Sim Center activity, the Holovision activity and one chapter of the Day in the Life docuseries. Each activity can be found on the RESTORE website when they are made available: https://restore-painrelief.com/cme-bridge/?portal=clinician.
TARGET AUDIENCE
Consistent with the goals of the FDA REMS blueprint, this REMS-compliant continuing education program is designed to meet the educational needs of a broad range of health care professionals, including physicians, advanced practice nurses (eg, APRN, CNS, NP, DNP, CRNA, CNMW, other), physician assistants, dentists, podiatrists, nurses, pharmacists, optometrists, and psychologists.
LEARNING OBJECTIVES
- Appraise best practices in patient and caregiver counseling regarding the safe use of naloxone for opioid overdose including proper and safe storage
- Describe the fundamental elements of addiction medicine and best practices for the identification and management of patients with opioid use disorder, including the discussion of the removal of stigmatizing language
JOINT ACCREDIDATION STATEMENT
In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CREDIT DESIGNATION STATEMENT
Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.
NURSES (ANCC) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of 0.5 ANCC contact hours.
PHARMACISTS AND PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION
Med Learning Group designates this activity for a maximum of up to 0.5 knowledge-based CPE contact hours.
NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.
AAPA CREDIT DESIGNATION STATEMENT – ENDURING MATERIALS
Med Learning Group has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designed for 0.5 AAPA Category 1 CME credit. Approval is valid until 1/31/2026. PAs should only claim credit commensurate with the extent of their participation.
ADA CREDIT DESIGNATION STATEMENT
Med Learning Group is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. Concerns or complaints about a CE provider may be directed to the provider or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
Med Learning Group designates this activity for 0.5 continuing education credits. Concerns or complaints about a CE provider may be directed to the provider, or to the Commission for Continuing Education Provider Recognition at CCEPR.ADA.org.
COPE CREDIT DESIGNATION STATEMENT
Med Learning Group designates this asynchronous activity for 0.5 COPE hours. Activity number 129875. Course number 95619-PH.
MATE ACT Designation Statement
This activity meets the MATE requirements set by the DEA and SAMHSA by covering prevention, recognition, and care of people with substance use disorders including those with concurrent pain and/or psychiatric and medical co-morbidities. This activity covers categories of substance use disorders, effective treatment planning, pain management and substance misuse. Completion of this activity will contribute to the 8 hour requirement set in the MATE ACT.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS
| Wei Sum Li, MD | Has nothing to disclose. |
| James Q. Zhou, MD | Has nothing to disclose. |
All relevant financial relationships have been mitigated.
Content Review
The content of this activity was independently peer reviewed by a physician and nurse reviewer.
Individuals in Control of the Content of the Activity
The individuals in control of the content of this activity reported the following financial relationships or relationships to products or devices they have with ineligible companies related to the content of this CE activity:
- Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
- Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
- Brianna Hefele, PA-C, has nothing to disclose.
- A medical reviewer from CME Peer Review LLC, has nothing to disclose.
- Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
- Nicole Longo, DO, FACOI, VP Med/Sci Services & Learner Engagement for Med Learning Group, has nothing to disclose.
- Lauren Scott, Medical Director for Med Learning Group, has nothing to disclose.
- Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
- Millena De Brito, Program Coordinator for Med Learning Group has nothing to disclose.
- Aimee Meissner, Accreditation and Outcomes Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CE credit for this activity.  In order to obtain your certificate for the mentioned accreditation, participants need to successfully complete the associated pre/post activities and evaluation. Your certificate will be provided as a downloadable file.
DISCLAIMER
Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.
For CE questions, please contact Med Learning Group at info@medlearninggroup.com
Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/
AMERICANS WITH DISABILITIES ACT
Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc). Please contact Med Learning Group at info@medlearninggroup.com
RELEASED DATE: February 10, 2025
EXPIRATION DATE: January 31, 2026
Copyright © 2025 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.
